Evaluating the Role of mpMRI in Prostate Cancer Assessment

par Mertan, Francesca V., Berman, Rose, Szajek, Kathryn, Pinto, Peter A., Choyke, Peter L., Turkbey, Baris
Publié dans Expert Rev Med Devices (2016)

WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy

par Sun, Lillian, Moore, Ellen, Berman, Rose, Clavijo, Paul E., Saleh, Anthony, Chen, Zhong, Van Waes, Carter, Davies, John, Friedman, Jay, Allen, Clint T.
Publié dans Oncoimmunology (2018)

DCE MRI of prostate cancer

par Berman, Rose M., Brown, Anna M., Chang, Silvia D., Sankineni, Sandeep, Kadakia, Meet, Wood, Bradford J., Pinto, Peter A., Choyke, Peter L., Turkbey, Baris
Publié dans Abdom Radiol (NY) (2016)

In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency

par Berman, Rose M., Kelada, Olivia J., Gutsche, Nicholas T., Natarajan, Raju, Swenson, Rolf E., Fu, Ying, Hong, Jessica, Ho, Mitchell, Choyke, Peter L., Escorcia, Freddy E.
Publié dans Cancer Biother Radiopharm (2019)

(18)F-DCFBC PSMA-Targeted PET/CT imaging in Localized Prostate Cancer: Correlation with mpMRI and Histopathology

par Turkbey, Baris, Mena, Esther, Lindenberg, Liza, Adler, Stephen, Bednarova, Sandra, Berman, Rose, Ton, Anita T., McKinney, Yolanda, Eclarinal, Philip, Hill, Craig, Afari, George, Bhattacharyya, Sibaprasad, Mease, Ronnie C., Merino, Maria J., Jacobs, Paula M., Wood, Bradford J., Pinto, Peter A., Pomper, Martin, Choyke, Peter L.
Publié dans Clin Nucl Med (2017)